Cellular and Functional Effects of Insulin Based Therapies and Exercise on Endothelium.

Current Pharmaceutical Design
Melissa A LuseBrant E Isakson

Abstract

Endothelial dysfunction is a hallmark of type 2 diabetes that can have severe consequences on vascular function, including hypertension and changes in blood flow, as well as exercise performance. Because endothelium is also the barrier for insulin movement into tissues, it acts as a gatekeeper for transport and glucose uptake. For this reason, endothelial dysfunction is a tempting area for pharmacological and/or exercise intervention with insulin-based therapies. In this review, we describe the current state of drugs that can be used to treat endothelial dysfunction in type 2 diabetes and diabetes-related diseases (e.g., obesity) at the molecular levels, and also discuss their role in exercise.

References

Apr 1, 1983·The Journal of Clinical Investigation·G L KingL I Rand
Sep 1, 1997·The Journal of Clinical Investigation·H O SteinbergA D Baron
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Mar 2, 2002·Journal of Diabetes and Its Complications·Shu WakinoWilla A Hsueh
Mar 29, 2002·Diabetes/metabolism Research and Reviews·Hans Hauner
Sep 28, 2002·Diabetes Care·Gabriele Fuchsjäger-MayrlMichael Wolzt
Oct 11, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Zsolt BagiGabor Kaley
Sep 9, 2004·American Journal of Physiology. Endocrinology and Metabolism·Thomas NyströmAke Sjöholm
Nov 25, 2005·Diabetes Care·Judith G RegensteinerJane E B Reusch
May 10, 2006·American Journal of Physiology. Endocrinology and Metabolism·Michelle A VincentEugene J Barrett
Aug 5, 2008·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Sebastian SixtJosef Niebauer
Dec 3, 2008·Expert Opinion on Emerging Drugs·Bo Ahrén
Jan 20, 2009·Current Medicinal Chemistry·Maria Assunta PotenzaMonica Montagnani
Jul 2, 2009·The Journal of Clinical Endocrinology and Metabolism·Zhenqi LiuEugene J Barrett
Feb 13, 2010·The Journal of Clinical Endocrinology and Metabolism·C MartinsJ E Blundell
Mar 5, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Robert S Lee-YoungDavid H Wasserman
May 15, 2010·Journal of Atherosclerosis and Thrombosis·Sadanori OkadaYoshihiro Miyamoto
Jul 21, 2010·The Journal of Physiology·Vitor A LiraDavid S Criswell
May 24, 2011·Diabetes Care·Normand G BouléDion R Brocks
Jun 21, 2011·Medicine and Science in Sports and Exercise·Karen R KellyJohn P Kirwan
Jul 27, 2011·Diabetes Care·Pleun C M van PoppelCees J Tack
Oct 21, 2011·Diabetes Care·Stefano BalducciUNKNOWN Italian Diabetes Exercise Study (IDES) Investigators

❮ Previous
Next ❯

Citations

Sep 8, 2020·Current Pharmaceutical Design·Leonardo Dos Santos

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.